Ticker Details
Vir Biotechnology, Inc.
IPO Date:	October 11, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.55B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.80 | 3.12%
Avg Daily Range (30 D):	$0.24 | 2.43%
Avg Daily Range (90 D):	$0.25 | 2.93%

Institutional Daily Volume
Avg Daily Volume:	1.09M
Avg Daily Volume (30 D):	1.34M
Avg Daily Volume (90 D):	2.58M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	99

Institutional Trades
Total Institutional Trades:	3,258
Avg Institutional Trade:	$2.42M
Avg Institutional Trade (30 D):	$1.85M
Avg Institutional Trade (90 D):	$1.93M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.44M
Avg Closing Trade (30 D):	$2.41M
Avg Closing Trade (90 D):	$2.76M
Avg Closing Volume:	188.93K

News

May 23, 2026 @ 10:13 PM Why a Biotech Fund Opened a New $6 Million Positio... Source: Jonathan Ponciano

May 14, 2026 @ 2:55 PM "Cold" Solid Tumors Become the Proving Ground for ... Source: World Street Intelligence News Commentary

Apr 12, 2026 @ 1:13 PM Vir Biotechnology (VIR) CEO Sells 73,000 Shares fo... Source: Cory Renauer

Feb 24, 2026 @ 1:31 PM Stock Market Today: S&P 500 Futures Slip As Dow, N... Source: Rishabh Mishra

Dec 7, 2025 @ 7:25 AM Is Alnylam Pharmaceuticals a Millionaire Maker? Source: Keith Speights

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.12	$-.85	$-.3
Diluted EPS	$-3.12	$-.85	$-.3
Revenue	$65.5M	$-.03M	$64.07M
Gross Profit
Net Income / Loss	$-442.72M	$-125.7M	$-42.92M
Operating Income / Loss	$-472.07M	$-132.29M	$-47.92M
Cost of Revenue
Net Cash Flow	$-84.95M	$41.97M	$61.81M
PE Ratio